Cargando…
Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
Cytomegalovirus (CMV) infection causes significant morbidity and mortality in lung transplant recipients. Current guidelines use pretransplant donor and recipient CMV serostatus to predict the risk of subsequent CMV replication and length of antiviral prophylaxis. Immunological monitoring may better...
Autores principales: | Li, Jenny, Gardiner, Bradley J., Stankovic, Sanda, Oates, Clare V. L., Cristiano, Yvonne, Levvey, Bronwyn J., Brooks, Andrew G., Snell, Gregory I., Westall, Glen P., Sullivan, Lucy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259634/ https://www.ncbi.nlm.nih.gov/pubmed/37313314 http://dx.doi.org/10.1097/TXD.0000000000001501 |
Ejemplares similares
-
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021) -
Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
por: Hiho, Steven J., et al.
Publicado: (2022) -
Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017) -
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022) -
Cytomegalovirus replication is associated with enrichment of distinct γδ T cell subsets following lung transplantation: A novel therapeutic approach?
por: Stankovic, Sanda, et al.
Publicado: (2020)